reference/23723959

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23723959

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2234-943X
pageRange	571517-
publicationName	Frontiers in Oncology
startingPage	571517
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f44e02fcf9fa27484f2fa88838529c69
bibliographicCitation	Gong Y, Hu N, Ma L, Li W, Cheng X, Zhang Y, Zhu Y, Yang Y, Peng X, Zou D, Tian J, Yang L, Mei S, Wang X, Lo CH, Chang J, Hou T, Zhang H, Xu B, Zhong R, Yuan P. ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer. Front Oncol. 2020;10():571517. PMID: 33102228; PMCID: PMC7545368.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_831cc7da0aaceffb971946c7a129162a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a6561810174ee477ba5218f44c2ec21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8f5b3596e68ba8e04b6635b9036a8dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08344a0fbbb984e757901b2162a58a86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_859569cfa5ecf3487498ebe6f6e669cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85d2dc01da8f8df3900957b4102f78e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8f8f763037f2731664644d6e7d6e204 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8202-4513 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_314d79e963e59eff0f85a7d97c24752c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0360c5fc7b1d4154b182d8f187a0246 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16ccd8783aa3259f3d954a95d9792bb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bf6a4e7de804f0637f1fcc5ff56bc47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f7bddcb5b2a4ac4d1b5452f20ab9e18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0c4c942b1fc7e293a4bf09a47b260f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_611950934eb543ee7482c0f39fd20026 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf6198dc74c03ca2b37346c267ba6de8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be23976bea6834189947cebf7804c66e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0344bd84b34949aeb006b3b3686798c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b88fa50823f03e6ac3985333a4cfe36e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc3ec5adeef3552c294e5e6cdd771194 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d58b98dea338d89498322d493672c35
date	2020-09-25^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7545368 https://doi.org/10.3389/fonc.2020.571517 https://pubmed.ncbi.nlm.nih.gov/33102228
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39509 https://portal.issn.org/resource/ISSN/2234-943X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7f88fb2c30c1ae73fd9068da16156030 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.12.8

Showing number of triples: 1 to 46 of 46.